#Germany #healthcare #Düsseldorf #Bredehorst Clinic #Sigla

Sigla Partners with Bredehorst Clinic to Enhance Healthcare Procurement in Germany

In a significant step towards revolutionizing the healthcare procurement landscape in Germany, Sigla, a private equity firm based in Europe, has announced its investment in Bredehorst Clinic Medical Management GmbH (BCMM). Known as the leading provider of tech-enabled procurement optimization for hospitals and care facilities, BCMM is positioned to enhance its services further through this partnership.

BCMM has cultivated a robust database over nearly two decades, comprising over five million invoice-level data points that empower it to provide granular insights and significant savings to healthcare providers, particularly hospitals. With increasing inflation and supply chain complexities putting financial strain on healthcare institutions, BCMM's services are more relevant than ever. The clinic improves procurement processes and helps hospitals generate substantial savings while enhancing operational efficiency.

A Strategic Partnership

The collaboration between Sigla and BCMM aims to accelerate the latter's expansion and digitize its operations, which will ultimately benefit German healthcare providers and related channel partners like Group Purchasing Organizations (GPOs). Sigla Fund I, from which the investment derives, is dedicated to building companies across specific sub-sectors in healthcare and business services.

Sigla brings with it over three decades of combined experience in healthcare investment in the DACH region (Germany, Austria, and Switzerland) and Northern Europe. Its partners have a history of involvement in various aspects of the German hospital procurement value chain, making them uniquely positioned to partner with BCMM. The deep-rooted relationship with BCMM's management underscores Sigla's operational engagement in this partnership.

Karl Geisel, Managing Partner at Sigla, articulated the importance of BCMM, stating, "BCMM has spent years earning the trust of some of Germany's most prominent hospital groups by delivering measurable savings for them while improving procurement quality. Demand for BCMM's services is high, and our objective is to enhance its capacity to meet this demand."

Strengthening Operations and Services

Phil Lesjak, another Managing Partner of Sigla, highlights BCMM as an ideal partner because of its clear leadership in the niche market, its proven business model, proprietary data assets, and unrivaled track record. With appropriate investment in technology, personnel, and thoughtful extensions to its offerings, Sigla sees a foundation for rapid growth in BCMM's core business and the potential for service expansion.

The demands placed on healthcare providers are growing significantly; Kim Königer, Managing Partner and Co-founder of BCMM, noted that clients require more than just cost reductions. They need comprehensive solutions that tackle procurement quality, supply chain security, and the underlying digital infrastructure facilitating every purchasing decision. The partnership with Sigla aims to broaden BCMM's service offerings meaningfully, leveraging Sigla's established track record within the sector.

Philipp Wenning, BCMM's other Managing Partner and Co-founder, emphasized the organization's evolution into the market leader in healthcare procurement optimization. He expressed excitement about partnering with Sigla to scale their successful model further, enhance digitization efforts, and solidify their data infrastructure, which is fundamental to their distinct service.

About BCMM and Sigla

Founded in 2006 and headquartered in Düsseldorf, BCMM offers healthcare procurement optimization services spanning all non-personnel cost categories, employing around 60 specialists. With over 180 engagements under its belt, BCMM works with many of Germany's most notable hospital groups and care associations.

Sigla, focused on specific segments within healthcare and business services, utilizes a hands-on approach to operational improvement and strategic initiatives. Its concentrated portfolio ensures that each investment receives precise attention to foster growth. The firm was established by Karl Geisel and Phil Lesjak and is ultimately backed by Nordstjernan AB, a family-controlled, foundation-owned Swedish investment house with a storied history of over 130 years in investing.

Learn more about BCMM at www.bredehorst-cmm.de and about Sigla at www.sigla-capital.com.